Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (S) 2 chloro 1 (3,4 difluorophenyl)ethanol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel catalytic transfer hydrogenation method for Ticagrelor intermediate. Reduces cost and toxicity compared to borane reduction. High ee value.
Discover advanced biocatalytic synthesis for ticagrelor intermediates using engineered ketoreductase. Achieve high substrate loading and cost reduction in pharmaceutical manufacturing.
Patent CN112063531B reveals a novel Geotrichum candidum strain for Ticagrelor intermediate synthesis, offering high stereoselectivity and reduced manufacturing costs.
Patent CN115011573B enables efficient synthesis of chiral alcohols with high substrate loading and reduced cofactor costs for pharmaceutical supply chains.
Patent CN111575334B reveals a stable immobilized enzyme method for synthesizing chiral alcohols, offering significant cost reduction and supply reliability for API manufacturing.